Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
Bone Marrow Transplantation|May 1, 1995
Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour RegistryR Ladenstein, C Lasset, R Pinkerton, et al.
British Journal of Cancer|June 1, 1995
Is neuroblastoma screening evaluation needed and feasible?J Estève, L Parker, P Roy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow TransplantationR Ladenstein, C Lasset, O Hartmann, et al.
Bulletin Du Cancer|July 1, 1993
[Treatment with cytokines of metastatic kidney cancer: the Lyon experience]S Négrier, A Mercatello, B Coronel, et al.
Bone Marrow Transplantation|September 1, 1989
Systemic interleukin-2 therapy in children with progressive neuroblastoma after high dose chemotherapy and bone marrow transplantationM C Favrot, D Floret, S Negrier, et al.
British Journal of Cancer|November 1, 1993
Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patientsT Philip, S Negrier, C Lasset, et al.
Bulletin Du Cancer|December 1, 1993
[Value of C-reactive protein determination in small cell lung cancer]D Arpin, V Trillet-Lenoir, C Lasset, et al.
Bulletin Du Cancer|January 1, 1992
[Comparison of 2 cisplatin and etoposide dosages in relapsing small cell lung cancer]V Trillet-Lenoir, C Lasset, D Arpin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphomaT Philip, O Hartmann, P Biron, et al.
Archives Francaises De Pediatrie|November 1, 1987
[Detection of residual cells contaminating the bone marrow in neuroblastoma. Apropos of 80 bone marrow evaluations]D Frappaz, O Maritaz, M C Favrot, et al.
Pageof 15